CRISPR-Cas9 is advancing Parkinson’s Disease research through precise gene editing, improved models, and emerging gene-therapy options.
Join global leaders discussing these breakthroughs at OTDC 2026.
🗓 May 25–26, 2026 | 📍 Rome, Italy
🔗
#
CRISPR# #
Cas9#